BioCatalystWatch
NAMSWorkspace / NAMS / OverviewCompany library
NewAmsterdam Pharma Co N.V. logo

NewAmsterdam Pharma Co N.V.

NewAmsterdam Pharma Co N.V. (NAMS)

Website

Price
Market cap
Next catalystExpected 2026Obicetrapib — BROADWAY · Phase 3 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

Obicetrapib

CETP

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Obicetrapib

CETP

PreINDP1P2P3FilingApproved
Upcoming / outlook

Obicetrapib

CETP

PreINDP1P2P3FilingApproved
Upcoming / outlook

Obicetrapib

CETP

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Obicetrapib

CETP

PreINDP1P2P3FilingApproved
Upcoming / outlook

Obicetrapib

CETP

PreINDP1P2P3FilingApproved
Upcoming / outlook

Obicetrapib

CETP

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Obicetrapib

CETP

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

Obicetrapib

CETP

PreINDP1P2P3FilingApproved
Obicetrapib

CETP

PreINDP1P2P3FilingApproved

Approved / commercial

Obicetrapib

CETP

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Obicetrapib + Ezetimibe Fixed-Dose Combination

CETP

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

NAMS PR & News

PR & News

NAMS SEC archive